SPERAGEN, INC.
Biotech · Private
Small molecule GHB receptor antagonists identified through pharmacophore modeling and virtual screening
speragen.com →- Grants
- $671K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Preclinical Evaluation of NCS-382 in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD) | $224,936 | |
| Federal grant | Department of Health and Human Services · Phase I · Farnesol as Novel Treatment in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD) | $223,095 | |
| Federal grant | Department of Health and Human Services · Phase I · In Silico Identification of Novel GHB Receptor Ligands for SSADH Deficiency, a Disorder of GABA Metabolism | $223,038 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3367 | SYNERGYS BIOTHERAPEUTICS, INC. | — | — |
| 3368 | COLLABORATIONS PHARMACEUTICALS INC | — | — |
| 3369 | Centivax Inc | — | — |
| 3370 | SPERAGEN, INC. | — | — |
| 3371 | SERVA ENERGY, INC. | — | $7.1M |
| 3372 | SwanBio Therapeutics | — | — |
| 3373 | Akston Biosciences Corp | — | $17M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.